<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="118579">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01559285</url>
  </required_header>
  <id_info>
    <org_study_id>PNU05-2011-054</org_study_id>
    <nct_id>NCT01559285</nct_id>
  </id_info>
  <brief_title>Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters</brief_title>
  <acronym>PNU</acronym>
  <official_title>Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pusan National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this trial, the investigators intend to examine whether the concentration of local
      anesthetics during epidural analgesia could be modulating factor for change of hemodynamics
      in patients undergoing major upper abdominal surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">May 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double Blind (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measure of hemodynamics</measure>
    <time_frame>during 1hour after administration of epidural drug dosing</time_frame>
    <description>Systolic blood pressure, diastolic blood pressure, MAP, HR, stroke volume, stroke volume, stroke volume index, stroke volume variation, cardiac output, and cardiac index were continuously measured at 5 minute intervals during 1 hour.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Epidural Anesthesia</condition>
  <condition>Ropivacaine Concentration</condition>
  <condition>Hemodynamics</condition>
  <arm_group>
    <arm_group_label>0.375% ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.375% ropivacaine 8ml was injected epidurally after induction of general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.75% ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.75% ropivacaine 8ml was injected epidurally after induction of general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.2% ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2% ropivacaine 8ml was injected epidurally after induction of general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.75% ropivacaine concentration</intervention_name>
    <description>0.75% ropivacaine 8ml was injected epidurally after induction of general anesthesia</description>
    <arm_group_label>0.75% ropivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.375% ropivacaine concentration</intervention_name>
    <description>0.375% ropivacaine 8ml was injected epidurally after induction of general anesthesia</description>
    <arm_group_label>0.375% ropivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.2% ropivacaine concentration</intervention_name>
    <description>0.2% ropivacaine 8ml was injected epidurally after induction of general anesthesia</description>
    <arm_group_label>0.2% ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: all of the followings needed.

          -  ASA I or II patients

          -  18 to 65 years old

          -  undergoing major upper abdominal surgery

          -  planned combined thoracic epidural analgesia and general anesthesia

        Exclusion Criteria:

          -  any contraindication to epidural analgesia

          -  allergy to local anesthetics of the amide type

          -  communication difficulties that would prevent reliable assessment

          -  known significant cardiac or respiratory disease

          -  pregnant

          -  patients who were not in cardiac sinus rhythm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyeon Jeong Lee, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Anesthesia, Pusan National University, School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyeon Jeong Lee, MD, PhD</last_name>
    <phone>82-51-240-7399</phone>
    <email>lhjksk@pusan.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pusan National University Yangsan Hospital</name>
      <address>
        <city>Yangsan</city>
        <zip>626770</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyeon Jeong Lee, MD, PhD</last_name>
      <phone>82-10-7680-7689</phone>
      <email>lhjksk@pusan.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Ji Uk Yoon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 24, 2013</lastchanged_date>
  <firstreceived_date>March 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pusan National University Hospital</investigator_affiliation>
    <investigator_full_name>Hyeon-Jeong Lee</investigator_full_name>
    <investigator_title>Assisstant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
